Authors: JOHNSTON SRD CONSTENLA DO MOORE J ATKINSON H AHERN RP DADIAN G RICHES PG GORE ME

Citation: Srd. Johnston et al., RANDOMIZED PHASE-II TRIAL OF BCDT [CARMUSTINE (BCNU), CISPLATIN, DACARBAZINE (DTIC) AND TAMOXIFEN] WITH OR WITHOUT INTERFERON-ALPHA (IFN-ALPHA) AND INTERLEUKIN (IL-2) IN PATIENTS WITH METASTATIC MELANOMA, British Journal of Cancer, 77(8), 1998, pp. 1280-1286

Authors: ROBINSON M ODONOHOE J DADIAN G WANKOWICZ A BARLTROP D HOBBS JR

Citation: M. Robinson et al., AN ANALYSIS OF THE NORMAL RANGES OF LYMPHOCYTE SUBPOPULATIONS IN CHILDREN AGED 5-13 YEARS, European journal of pediatrics, 155(7), 1996, pp. 535-539

Authors: SALTER J MACLENNAN KA MOORE J DADIAN G RICHES PG GORE ME

Citation: J. Salter et al., THE PHENOTYPIC CHANGES IN TUMOR-INFILTRATING LYMPHOCYTES AND TUMOR-CELLS FOLLOWING INTRAARTERIAL INFUSION OF INTERLEUKIN-2 IN PATIENTS WITHSQUAMOUS-CELL CARCINOMA, Journal of pathology, 176(2), 1995, pp. 167-173

Authors: GOODING R RICHES P DADIAN G MOORE J GORE M

Citation: R. Gooding et al., INCREASED SOLUBLE INTERLEUKIN-2 RECEPTOR CONCENTRATION IN PLASMA PREDICTS A DECREASED CELLULAR-RESPONSE TO IL-2, British Journal of Cancer, 72(2), 1995, pp. 452-455

Authors: DADIAN G RICHES PG HENDERSON DC TAYLOR A MOORE J ATKINSON H GORE ME

Citation: G. Dadian et al., IMMUNOLOGICAL PARAMETERS IN PERIPHERAL-BLOOD OF PATIENTS WITH RENAL-CELL CARCINOMA BEFORE AND AFTER NEPHRECTOMY, British Journal of Urology, 74(1), 1994, pp. 15-22